Literature DB >> 12225450

The neurobehavioural effects of kava.

Sheree Cairney1, Paul Maruff, Alan R Clough.   

Abstract

OBJECTIVE: This review considers the context in which kava is used, together with its underlying psychopharmacological mechanisms, to investigate the neurobehavioural effects associated with kava use.
METHOD: We conducted a systematic search using the computerized databases MEDLINE, OVID and PsychLIT for all articles containing any of the following words: kava, kavain, kawa and Piper methysticum. In the opinion of the authors, all articles from this collection containing data that could inform the neurological and cognitive sequelae of kava use were included for the purpose of this review.
RESULTS: The use of kava occurs among indigenous populations in the South Pacific and in northern Australia, while also being used throughout the western world as a herbal medicine. Animal studies show that kava lactones alter neuronal excitation through direct interactions with voltage-dependent ion channels, giving rise to kava's muscle relaxant, anaesthetic, anxiolytic and anticonvulsive properties. Several isolated cases of psychotic and severe dystonic reactions following kava use suggest that kava also has psychoactive properties, yet there is no conclusive evidence that kava interferes with normal cognitive processes.
CONCLUSIONS: Kava is effective in the treatment of tension and anxiety. There may be risk-factors for severe motor and psychiatric responses to kava use, although these are not well-understood. Given the increasingly widespread use of kava, further investigation is necessary to gain an understanding of its immediate neuropsychiatric effects and long-term cognitive effects.

Entities:  

Mesh:

Year:  2002        PMID: 12225450     DOI: 10.1046/j.1440-1614.2002.01027.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  10 in total

Review 1.  Management of anxiety and sleep disorders: role of complementary and alternative medicine and challenges of integration with conventional orthodox care.

Authors:  Martins Ekor; Oluyomi S Adeyemi; Chiagoziem A Otuechere
Journal:  Chin J Integr Med       Date:  2012-12-29       Impact factor: 1.978

2.  Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways.

Authors:  Ping Zhou; Shimon Gross; Ji-Hua Liu; Bo-Yang Yu; Ling-Ling Feng; Jan Nolta; Vijay Sharma; David Piwnica-Worms; Samuel X Qiu
Journal:  FASEB J       Date:  2010-08-09       Impact factor: 5.191

3.  Ex vivo and in vitro inhibitory potential of Kava extract on monoamine oxidase B activity in mice.

Authors:  Bárbara Nunes Krum; Catiuscia Molz de Freitas; Alcindo Busanello; Larissa Finger Schaffer; Roselei Fachinetto
Journal:  J Tradit Complement Med       Date:  2021-07-14

4.  How does male ritual behavior vary across the lifespan? An examination of Fijian kava ceremonies.

Authors:  John H Shaver; Richard Sosis
Journal:  Hum Nat       Date:  2014-03

5.  A re-evaluation of kava (Piper methysticum).

Authors:  E Ernst
Journal:  Br J Clin Pharmacol       Date:  2007-06-06       Impact factor: 4.335

6.  Development and piloting of the Fiji Injury Surveillance in Hospitals System (TRIP Project-1).

Authors:  I Wainiqolo; B Kafoa; E McCaig; B Kool; R McIntyre; S Ameratunga
Journal:  Injury       Date:  2011-11-17       Impact factor: 2.586

Review 7.  Herbal Highs: Review on Psychoactive Effects and Neuropharmacology.

Authors:  Silvia Graziano; Laura Orsolini; Maria Concetta Rotolo; Roberta Tittarelli; Fabrizio Schifano; Simona Pichini
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  Driving following Kava Use and Road Traffic Injuries: A Population-Based Case-Control Study in Fiji (TRIP 14).

Authors:  Iris Wainiqolo; Berlin Kafoa; Bridget Kool; Elizabeth Robinson; Josephine Herman; Eddie McCaig; Shanthi Ameratunga
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

9.  Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.

Authors:  Han Chow Chua; Emilie T H Christensen; Kirsten Hoestgaard-Jensen; Leonny Y Hartiadi; Iqbal Ramzan; Anders A Jensen; Nathan L Absalom; Mary Chebib
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

Review 10.  Kava as a Clinical Nutrient: Promises and Challenges.

Authors:  Tengfei Bian; Pedro Corral; Yuzhi Wang; Jordy Botello; Rick Kingston; Tyler Daniels; Ramzi G Salloum; Edward Johnston; Zhiguang Huo; Junxuan Lu; Andrew C Liu; Chengguo Xing
Journal:  Nutrients       Date:  2020-10-05       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.